Clinical and Pathological Aspects of Canine Cutaneous Leishmaniasis: A Meta-analysis
- 40 Downloads
In the present study, we described the most prevalent clinical symptoms, the most affected organs, and the macro and microscopic lesions associated with cutaneous leishmaniasis.
Two independent researchers performed an extensive systematic review of the literature in four stages (identification, screening, eligibility, and inclusion) to identify studies published between January 2002 and November 2018 from the following electronic databases: Web of Science, PubMed, SciELO, Science Direct, and Google Scholar. Meta-analysis was conducted in “Metaprop” package of R 3.4.2 software.
The electronic search yielded 3896 results, out of which 155 were further analyzed based on the full-text. Data extracted from 16 articles were included in the meta-analysis, representing a total of 430 leishmaniasis cases. Only 43% of all animals were identified to exhibit the clinical and cutaneous changes characteristic of leishmaniasis based on the observation that skin lesions were the most prevalent clinical sign and were present in 86% of all cases. Other less prevalent symptoms included weight loss, cachexia, apathy and lymph node enlargement. Histopathological analysis showed that the skin was the most affected organ, affecting 64% of cases, followed by lymph nodes (12%), spleen (8%) and liver (7%).
Therefore, our current findings suggest that cutaneous leishmaniasis could lead to visceral disease. Notably, our findings indicated no clinical manifestation patterns in cutaneous leishmaniasis, since the same host species may present different clinical conditions.
KeywordsLeishmania Dog Clinical condition Histopathology Meta-analysis
- 5.Calzada JE, Saldaña A, González K, Rigg C, Pineda V, Santamaría AM, Rodríguez I, Gottdenker NL, Laurenti MD, Chaves LF (2015) Cutaneous leishmaniasis in dogs: is high seroprevalence indicative of a reservoir role? Parasitology 142(9):1202–1214. https://doi.org/10.1017/S0031182015000475 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Gavgani ASM, Hodjati MH, Mohite H, Davies CR (2002) Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360(9330):374–379. https://doi.org/10.1016/S0140-6736(02)09609-5 CrossRefPubMedGoogle Scholar
- 16.Hashiguchi Y, Eduardo A, Gomez L, Cáceres AG, Velez LN, Villegas NV, Hashiguchi K, Mimori T, Uezato H, Kato H (2018) Andean cutaneous leishmaniasis (Andean-CL, uta) in Peru and Ecuador: the vector Lutzomyia sand flies and reservoir mammals. Acta Trop 178:264–275. https://doi.org/10.1016/j.actatropica.2017.12.008 CrossRefPubMedGoogle Scholar
- 18.Lage RS, Oliveira GC, Busek SU, Guerra LL, Giunchetti RC, Corrêa-Oliveira R, Reis AB (2007) Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi. Vet Immunol Immunopathol 115(1–2):135–145. https://doi.org/10.1016/j.vetimm.2006.10.001 CrossRefPubMedGoogle Scholar
- 19.Marco JD, Padilla AM, Diosque P, Fernández MM, Malchiodi EL, Basombrío MA (2001) Force of infection and evolution of lesions of canine tegumentary leishmaniasis in Northwestern Argentina. Mem Inst Oswaldo Cruz 96(5):649–652. https://doi.org/10.1590/S0074-02762001000500009 CrossRefPubMedGoogle Scholar
- 27.Tirelli F, Vernal S, Roselino AM (2017) Final diagnosis of 86 cases included in differential diagnosis of American tegumentary leishmaniasis in a Brazilian sample: a retrospective cross-sectional study. Ann Bras Dermatol 92(5):642–648. https://doi.org/10.1590/abd1806-4841.20175794 CrossRefGoogle Scholar
- 28.Torrentera FA, Lambot MA, Laman JD, Meurs MV, Kiss R, Noël JC, Carlier Y (2002) Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana. Am J Trop Med Hyg 66(3):273–279. https://doi.org/10.4269/ajtmh.2002.66.273 CrossRefGoogle Scholar
- 31.WHO—World Health Organization (2010) Control of leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. WHO technical report series, Geneva, no. 949Google Scholar